Skip to content

Evaluation of the Efficacy of Hippotherapy for Children With Developmental Disorders

Evaluation of the Efficacy of Hippotherapy for Children With Developmental Disorders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00717392
Enrollment
40
Registered
2008-07-17
Start date
2008-09-30
Completion date
2012-07-31
Last updated
2013-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder

Keywords

ADHD, ASD

Brief summary

Hippotherapy is every program of horseback riding meant to treat people with physiological, mental, social, cognitive or behavioral problems. The purpose of the current research is to evaluate the efficacy of hippotherapy for children with developmental disabilities. The hypothesis is that children with developmental disabilities who are treated with hippotherapy will show better outcomes than children with the same problems who are not treated with hippotherapy.

Detailed description

Hippotherapy is every program of horseback riding meant to treat people with physiological, mental, social, cognitive or behavioral problems. Most studies that tested hippotherapy were uncontrolled and focused on motor problems, such as cerebral palsy. Today, hippotherapy is used for various developmental problems such as Attention deficit / Hyperactivity disorder (ADHD) and Autism spectrum disorder (ASD), without clear information about its efficacy for these populations. The purpose of the current research is to evaluate the efficacy of 6 months of hippotherapy for children with developmental disabilities. The hypothesis is that children with developmental disabilities who are treated with hippotherapy for 6 months will show better outcomes than children with the same problems who are not treated with hippotherapy. Assessment: * BRIEF questionnaire * Stony Brook Questionnaire All questionnaires will be applied at the beginning of the study and after 6 months.

Interventions

None listed

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Age: 5-17 years. * A diagnosis of ADHD or ASD.

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frameDescription
Improving the parameters of autismRepetitive behaviorsRepetitive behaviors Eye contact Communication

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026